Low Vaccination Concerns Highlight Need for Fall and Winter 2023 Vaccination Campaigns
Cases of COVID-19, RSV, and influenza are expected to rise this fall and winter season; yet, the number of people who plan on getting the vaccines for each of the infections remains low, according to the NFID announcement today.
The Critical Role of Data-Driven Action in the Fight Against COVID-19
Deborah Birx, MD, highlights concerns about the lack of data-driven action in the fight against COVID-19. She emphasizes the need for timely alerts and empowering communities to protect vulnerable individuals.
Understanding the Environmental Spread of Emerging Pathogens
The AHE Exchange Conference in Dallas focused on emerging pathogens and the role of environmental services. Doe Kley, MPH, RN, T-CHEST, LTC-CIP, CIC, discusses her and other exceptional presentations with Infection Control Today.
Fall 2023: Mask Mandates for Students Amidst COVID-19 and Latest Variant Concerns
Ambassador Deborah Birx, MD, discusses whether students should be required to wear masks to protect themselves and others and what the public should know about the newest COVID-19 variant, B.A.2.86.
Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy
Randomized controlled trials show masks are effective. With COVID-19, even one mistake in protective gear usage could lead to infection and obscure results.
Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership
In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.
Moderna’s Vaccine Showing Robust Response Against 4 Influenza Strains
Besides its influenza pipeline, mRNA technology is helping this pharmaceutical company create a number of new vaccines for cancer, rare diseases, and infectious diseases.
CDC Publishes 2 Reports on Hepatitis Incidence Rates and Progress Towards 2025 Goals
Hepatitis C cases increased in 2021, while A and B decreased. The pandemic may have impacted the progress.
Update: Dr. Berne’s MSM Eye Drops Are Voluntarily Recalled
All eye drops from Dr. Berne’s Whole Health Products are being recalled after FDA warning on August 24. There are 2 adverse reactions reported so far.
CDC Launches a New Sepsis Guide for Hospitals
This guide aims to assist hospitals in identifying and managing sepsis at an earlier stage. ICT interviews 1 of the authors.
Eagle Pharmaceuticals Announces Phase 2 Study for Anti-Toxin Drug Candidate for SCABP
Eagle Pharmaceuticals randomized its first patient in the Phase 2 study of CAL02, a safe and promising anti-toxin drug that treats severe community-acquired bacterial pneumonia without contributing to antibiotic resistance.
Weekly Rounds: Moderna's Updated Vaccine, COVID-19 News, White Coats, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending Aug 20, 2023.
Hot Topics in IPC: New Leadership, Tuberculosis, and COVID-19 Updates
In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, tuberculosis, and changes in leadership at the CDC and NIAID.
Are You Reinventing the Wheel?
Connecting and networking with colleagues, finding the right resources, and joining key organizations can help you become a better infection preventionist.
Weekly Rounds: The Correct Disinfectant, Changing Belief Systems, and More
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending July 30, 2023.
With STI Cases Rising, Preventx Enters US Market
A new remote sexual health testing provider is available to US public health officials. It aims to reduce the increasing spread of sexually transmitted infections.
One Step Forward, 2 Back: CDC's Proposals for Infection Control in Health Care Facilities
In this opinion article, the authors discuss their concerns about the recent HICPAC/CDC proposals on infectious diseases.
Parker’s High-Level Disinfectant Foam Receives FDA de novo Clearance
Neal Buchalter, MBA, president of Parker Laboratories, spoke with Infection Control Today® in an exclusive interview about the product, the companies involved, and how it came to the US market.
FDA Approves RSV Drug for Children Up to 24 Months
AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.
Opinion: Post Pandemic Strategies Are Inadequate To Assure Public Safety
In his analysis, Kevin Kavanagh, MD, explores the measures taken by the infectious disease sector in response to the pandemic, pointing out both effective and ineffective approaches. He also discusses how the pandemic has affected the treatment of other infectious diseases.
Majority of Patients With Long COVID Meet Criteria for POTS
A small study explored the connection between Postural Orthostatic Tachycardia Syndrome (POTS) and the COVID-19 condition.
The Importance of Health Equity in Infection Prevention and Control
A session held at the APIC 2023 Annual Conference & Exhibition delved into the importance of equity in infection prevention and explored the impact of health inequities on the transmission of diseases.
New study shows COVID-19 infections in 2 pregnant women caused brain damage in newborns
Investigators studied 2 infants experiencing seizures, small head size, and developmental delays born of mothers who had contracted COVID-19 during pregnancy.
Two Cases of Legionnaires’ Disease Linked to Public Gym in Illinois
Legionnaires’ disease is a severe infection and fatal in 10% of cases.
Opinion: COVID-19 Expanded Reporting Systems Should Continue
Establishing a permanent system for monitoring the persistence and emergence of dangerous pathogens is necessary, especially COVID-19.
Breaking: FDA Approves First-Ever RSV Vaccine
The vaccine is approved for use in adults aged 60 and older to prevent lower respiratory tract disease caused by RSV.
Hot Topics in IPC: STI Antibiotic Plans, Marburg, COVID-19, and Medicine's Rat Problem
Saskia v. Popescu, PhD, MPH, MA, CIC, gives the latest on COVID-19, Marburg Virus Disease, and a 1-hit STI antibiotic plan.
Weekly Rounds: Marburg in the Lab, IPs' Role in Dentistry, and IP Risk in Water Management
Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending April 23, 2023.
AMDAC Votes Unanimously in Favor of Possible Bacterial Pneumonia Therapy
Sulbactam-durlobactam is under priority review (PDUFA; May 29, 2023).
Candida auris: Using Public Health Messaging to Address Prevention
Despite the recent CDC warning and frightening media coverage, understanding which patients are at a higher risk of Candida auris is important too. The lead author of the recent CDC's study spoke to ICT's sister brand for further insights on the threat.
2 Clarke Drive Cranbury, NJ 08512